Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Micron Tech’s Q4 Results Beat – Analyst Blog

Zacks Market Commentaries (September 30th, 2009) Writes:
Micron Technology Inc. (MU), a provider of advanced semiconductor solutions fourth-quarter of 2009 earnings beat the Zacks Consensus Estimate by 9 cents. The company posted a net loss of 10 cents per share, much better than the 45 cents loss reported in the year-ago period and 36 cents in the previous quarter as demand and price for memory chips improved. Revenue for the quarter was $1.30 billion, down 10.1% from the year-ago period. However, revenue was above the consensus estimate of $1.27 billion and increased sequentially by 17.7%. We remain encouraged by the company’s continued cost reduction initiatives while pursuing strategic alternatives with tighter capital expenditures and operating expenses. During the quarter operating expenses declined 19.3%, primarily due to lower R&D expenses which fell 16.8%, and lower SG&A expenses which declined 23.4% year over year. Micron’s memory and image-sensing chips are used by International Business ...

MU, EQLB, PWRM, DrStockPick.com Watch List! for Tuesday September 29, 2009, Micron Technology Inc., EQ Labs Inc., EQLB.PK and Power 3 Medical Products Inc, PWRM.OB

Dr. Stock Pick (September 28th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

DrStockPick.com Watch List!

My Picks for Tuesday September 29, 2009, are:

**************************************************************

MU, Micron Technology Inc.

MU together with its subsidiaries, engages in the manufacture and marketing of semiconductor devices worldwide. Its products include dynamic random access memory (DRAM) products that provide data storage and retrieval, which include DDR, DDR2, DDR3, synchronous DRAM, and other specialty DRAM memory products, such as mobile DRAM, pseudo-static RAM, and reduced latency DRAM.

Because of the back of strong memory prices and robust shipments, the expectations about MU would beat Wall Street’s earnings and revenue forecast for the fourth quarter

...

CVAT, JNJ, CSRH, MRK, PWRM, MU, DrStockPick.com Stock Report!

Dr. Stock Pick (September 25th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Friday September 25, 2009

DrStockPick.com Stock Report!

CVAT, JNJ, CSRH, MRK, PWRM, MU

**************************************************************

CSRH, Consorteum Holdings Inc, CSRH.OB

CSRH is a company in the financial services, payment and transaction processing industries.

CSRH provides electronic transaction processing and management services to financial institutions, healthcare, government, public and private sector companies. CSRH’s services provide customized, innovative technology solutions that create, augment and enhance customers’ existing financial, payment and transactional processing systems.

CSRH has established an agreement with a third party partner within the payment processing industry to offer Merchant Discount Rates. Consorteum will leverage this new partnership to offer competitive Merchant Discount Rates and Point of

...
Tags for this Post:
advertisement services, advertising services, Allergy, ALS, Argentina, Beijing, beverage, Breast Cancer, broker, cancer, Cavitation Technologies Inc., ceo, Chair and Keynote Speaker, chemical industries, chief scientific officer, China, Congress, Consorteum Holdings Inc.;, credit card transaction processing, Crown Equity Holdings Inc.;, CSRH, Diabetes, Diabetes and Obesity, diagnostic tests, Dow Chemical, Dr Stock Pick, electronic transaction processing;, energy efficient lighting products, equity trader, Fda, Financial Services, food, Franchise Head, healthcare, Houston, human health pharmaceutical products, Idaho, Inc, infants, International Congress, Investing Lessons, Ira Goldknopf, John Amatruda, Johnson & Johnson, Latin America, leader in the development, memory products, Merck, Merck Co, Merck Research Laboratories, Micron Technology Inc.;, MOTRIN IB, MRK, neurodegenerative disease;, North America, nutritional and over-the-counter pharmaceutical products, obesity, outdated technologies, pancreatitis, payment processing industry, PEPCID AC, physician, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, president, President & COO, professional investment analyst and consultant, Quent Rickerby;, Random Access;, Roman Gordon, semiconductor devices, stock featured on our site;, Stock Pick, Stocks to Watch, technology solutions, Texas, transaction processing industries;, transactional processing systems;, Tylenol, U.S. Food and Drug Administration, United States, USD, vegetable oil refining, Vice President and Franchise Head, www.alsbio.com, www.consorteum.com, www.crowntradingsystems.com, www.crwenews.com, www.dow.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com

Spansion Seeks Expansion – Analyst Blog

Zacks Market Commentaries (September 24th, 2008) Writes:

Sunnyvale, California-based Spansion (SPSN) is a semiconductor device company exclusively dedicated to designing, developing, manufacturing, marketing and selling Flash memory solutions. The firm's Flash memory is integrated into a broad range of electronic products, including mobile phones, consumer electronics, networking and telecommunications equipment, and computer peripherals.

Flash memory products are generally based on either NOR or NAND architecture. To date, Spansion's Flash memory products have been based on NOR architecture, which are typically produced at a higher cost-per-bit than NAND-based products.

The Saifun acquisition opens the company up to the technology licensing business, which historically has had very high margins. The imbalance between NOR and NAND will continue and investors should watch the traction of the few NAND products the firm does have. We feel the firm will trade at current to slightly higher valuation metrics until the 2008-2009 demand outlook becomes a little more clear. We are setting a

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.